The updated artificial intelligence improves the EPIQ systems’ automated 2D assessments and 3D measurements of right ventricle volume and ejection fraction. According to Philips, the new applications allow clinicians to accurately evaluate heart function even faster and easier than before, and with less variability between scans, increasing their diagnostic confidence in cases of pulmonary hypertension, congenital heart disease, coronary disease and heart failure.
Additionally, the new system requires fewer touches from clinicians to perform each scan: a reduction of 21 percent per exam, or the equivalent of more than 400 exams each year.
More articles about AI:
AI-guided robotic device replaces endoscopy in diagnosing colon cancer
Blackstone CEO donates $190M to Oxford for AI ethics research
Most companies spend at least $51,000 on AI, report finds: 4 notes
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.